A Clinical Study of TQB3616 Capsules Combined With Anlotinib Hydrochloride Capsules or Standard Chemotherapy Second-line and Above in the Treatment of Advanced Lung Cancer
Clinical trial NCT04924192 · TERMINATED
Trial details
- NCT number
- NCT04924192
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-18
- Primary completion
- 2022-09-27
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.